BDSyn Bio Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $4.22M

  • Investors
  • 1

BDSyn Bio General Information

Description

Manufacturer of vaccine adjuvant technologies designed to enhance the safety, potency, and performance of next-generation immunisation products. The company offers single-structure adjuvants produced under stringent manufacturing standards alongside tailored formulation development and immunological assessment, enabling global vaccine developers to access reliable adjuvant supply and achieve superior efficacy in vaccine research and production.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • D2-10, Overseas Students Entrepreneurship Park
  • Jiulongpo District
  • Chongqing
  • China
+86 133
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Corporate Office
  • D2-10, Overseas Students Entrepreneurship Park
  • Jiulongpo District
  • Chongqing
  • China
+86 133

BDSyn Bio Timeline

202420252026
Date FoundedFinancing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BDSyn Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 21-Nov-2025 $4.22M Completed Generating Revenue
2. Secondary Transaction - Private 09-Jan-2025 Completed Generating Revenue
1. Early Stage VC 30-Sep-2024 Completed Generating Revenue
To view BDSyn Bio’s complete valuation and funding history, request access »

BDSyn Bio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
LH Ventures (China) PE/Buyout Minority
To view BDSyn Bio’s complete investors history, request access »

BDSyn Bio FAQs

  • When was BDSyn Bio founded?

    BDSyn Bio was founded in 2023.

  • Where is BDSyn Bio headquartered?

    BDSyn Bio is headquartered in Chongqing, China.

  • What industry is BDSyn Bio in?

    BDSyn Bio’s primary industry is Biotechnology.

  • Is BDSyn Bio a private or public company?

    BDSyn Bio is a Private company.

  • What is BDSyn Bio’s current revenue?

    The current revenue for BDSyn Bio is .

  • How much funding has BDSyn Bio raised over time?

    BDSyn Bio has raised $4.22M.

  • Who are BDSyn Bio’s investors?

    LH Ventures (China) has invested in BDSyn Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process